This is the patient version of the EULAR recommendations for the management of glucocorticoid medicines in people with rheumatic diseases. The original publication can be downloaded from the EULAR website: www.eular.org. INTRODUCTION Glucocorticoids (prednisone or prednisolone) are medicines to reduce inflammation. They are used in rheumatic diseases such as rheumatoid arthritis, polymyalgia, lupus and vasculitis […]
Month: August 2016
Newly updated advice on the treatment of patients with AAV
INTRODUCTION A central focus of newly updated recommendations on treating ANCA-associated vasculitis (AAV) is shared decision-making between patients and doctors. The updated recommendations, produced by a collaboration between the European League Against Rheumatism (EULAR) and European Renal Association – European Dialysis and Transplant Association (ERA-EDTA), taking account of recent research on the benefits and safety […]
Continuous NSAID offers no benefit over on-demand in ankylosing spondylitis
More evidence is needed to confirm whether continuous NSAID can reduce joint damage in people with ankylosing spondylitis. INTRODUCTION Ankylosing spondylitis is a chronic inflammatory disease. It mainly involves the joints, but may be associated with other diseases, such as psoriasis (a skin disease), inflammatory bowel disease and uveitis (an inflammation in the eye). These […]
Treatment-free remission may soon be a realistic goal in rheumatoid arthritis
Tapering and sometimes discontinuation of DMARDS is possible in people with rheumatoid arthritis who achieve sustained remission, hinting at the possibility that the disease could be cured. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that causes pain and disability. It can also affect internal organs. Rheumatoid arthritis is more common in older people, but […]
